Omega Therapeutics, Inc. logo

Omega Therapeutics, Inc.

NASDAQ:OMGA

Overview | Financials
Company Name Omega Therapeutics, Inc.
Symbol OMGA
Currency USD
Price 1.98
Market Cap 109,206,900
Dividend Yield 0%
52-week-range 1.3 - 8.88
Industry Biotechnology
Sector Healthcare
CEO Mr. Mahesh Karande
Website https://www.omegatherapeutics.com

An error occurred while fetching data.

About Omega Therapeutics, Inc.

Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a,

Related Stocks

Societal CDMO, Inc. logo

Societal CDMO, Inc.

SCTL

1.1 USD

Vascular Biogenics Ltd. logo

Vascular Biogenics Ltd.

VBLT

0.156 USD

INmune Bio, Inc. logo

INmune Bio, Inc.

INMB

9.65 USD

Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc.

ATOS

1.32 USD

Portage Biotech Inc. logo

Portage Biotech Inc.

PRTG

0.256 USD

FONAR Corporation logo

FONAR Corporation

FONR

15.27 USD

Financials

Numbers are in millions USD

Numbers are in millions USD